Evidence map›Paper›PMID 29748550›Full record

ArticleScientific reports2018

Novel method for rapid toxicity screening of magnetic nanoparticles.

A Erofeev, P Gorelkin, A Garanina, A Alova, M Efremova, N Vorobyeva, C Edwards, Y Korchev, A Majouga

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
5.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 95 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 3 countries.

A ErofeevNational University of Science and Technology «MISIS», Leninskiy prospect 4, 119049, Moscow, Russian Federation. erofeev@polly.phys.msu.ru.
P GorelkinMedical Nanotechnology LLC, Skolkovo Innovation Center, 121205, Moscow, Russian Federation.
A GaraninaNational University of Science and Technology «MISIS», Leninskiy prospect 4, 119049, Moscow, Russian Federation.ORCID 0000-0003-3442-9553
A AlovaLomonosov Moscow State University, Leninskiye gory, GSP-1, 119991, Moscow, Russian Federation.
M EfremovaNational University of Science and Technology «MISIS», Leninskiy prospect 4, 119049, Moscow, Russian Federation.ORCID 0000-0002-5196-5596
N VorobyevaNational University of Science and Technology «MISIS», Leninskiy prospect 4, 119049, Moscow, Russian Federation.
C EdwardsDepartment of Medicine, Imperial College London, London, W12 0NN, United Kingdom.
Y KorchevDepartment of Medicine, Imperial College London, London, W12 0NN, United Kingdom.
A MajougaNational University of Science and Technology «MISIS», Leninskiy prospect 4, 119049, Moscow, Russian Federation.
National University of Science and Technology · RUImperial College London · GBKanazawa University · JPLomonosov Moscow State University · RUSkolkovo Foundation · RU

Funding

Biotechnology and Biological Sciences Research Council BB/D020875/1
6 · The paper itself

Abstract

Iron oxide nanoparticles have attracted a great deal of research interest and have been widely used in bioscience and clinical research including as contrast agents for magnetic resonance imaging, hyperthermia and magnetic field assisted radionuclide therapy. It is therefore important to develop methods, which can provide high-throughput screening of biological responses that can predict toxicity. The use of nanoelectrodes for single cell analysis can play a vital role in this process by providing relatively fast, comprehensive, and cost-effective assessment of cellular responses. We have developed a new method for in vitro study of the toxicity of magnetic nanoparticles (NP) based on the measurement of intracellular reactive oxygen species (ROS) by a novel nanoelectrode. Previous studies have suggested that ROS generation is frequently observed with NP toxicity. We have developed a stable probe for measuring intracellular ROS using platinized carbon nanoelectrodes with a cavity on the tip integrated into a micromanipulator on an upright microscope. Our results show a significant difference for intracellular levels of ROS measured in HEK293 and LNCaP cancer cells before and after exposure to 10 nm size iron oxide NP. These results are markedly different from ROS measured after cell incubation with the same concentration of NP using standard methods where no differences have been detected. In summary we have developed a label-free method for assessing nanoparticle toxicity using the rapid (less than 30 minutes) measurement of ROS with a novel nanoelectrode.

Indexed as

ApoptosisCell Line, TumorHEK293 CellsHumansMagnetite NanoparticlesMicroelectrodesReactive Oxygen SpeciesTime FactorsToxicity TestsMagnetite NanoparticlesReactive Oxygen Species

Identifiers

PMID29748550
PMCPMC5945642
OpenAlexW2805723146

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.